Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Clarivate
CLVT
$1.16B
| $2.37M | ﹤0.01% |
283,582
-46,889
| -14% | -$440K |
|
|
UMH
2102
UMH Properties
UMH
$1.36B
| $2.36M | ﹤0.01% |
146,765
+18,533
| +14% | +$312K |
|
2103
Innovative Industrial Properties
IIPR
$1.72B
| $2.36M | ﹤0.01% |
23,293
-16,885
| -42% | -$1.8M |
|
|
TWNK
2104
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $2.36M | ﹤0.01% |
105,164
+12,604
| +14% | +$317K |
|
2105
Fastly Inc
FSLY
$3.66B
| $2.36M | ﹤0.01% |
288,109
-54,512
| -16% | -$477K |
|
2106
Global Ship Lease
GSL
$1.53B
| $2.36M | ﹤0.01% |
141,652
| – | – |
|
|
DAWN
2107
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.36M | ﹤0.01% |
109,552
+19,123
| +21% | +$392K |
|
2108
RBC Bearings
RBC
$18B
| $2.36M | ﹤0.01% |
11,260
+4,830
| +75% | +$1.1M |
|
2109
SPS Commerce
SPSC
$2.64B
| $2.35M | ﹤0.01% |
18,331
+5,631
| +44% | +$726K |
|
2110
Columbia Banking Systems
COLB
$8.84B
| $2.35M | ﹤0.01% |
78,086
+27,986
| +56% | +$889K |
|
|
CWEN.A
2111
DELISTED
Clearway Energy Class A
CWEN.A
| $2.35M | ﹤0.01% |
78,613
+15,092
| +24% | +$471K |
|
2112
CVB Financial
CVBF
$3.99B
| $2.35M | ﹤0.01% |
91,199
+15,419
| +20% | +$420K |
|
|
IGTA
2113
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
| $2.35M | ﹤0.01% |
231,806
| – | – |
|
|
SLVRW
2114
DELISTED
SilverSPAC Inc. Warrant
SLVRW
| $2.34M | ﹤0.01% |
233,333
| – | – |
|
|
PDCE
2115
DELISTED
PDC Energy, Inc.
PDCE
| $2.34M | ﹤0.01% |
36,885
-19,553
| -35% | -$1.36M |
|
|
AGEN
2116
Agenus
AGEN
$290M
| $2.34M | ﹤0.01% |
49,670
+2,759
| +6% | +$140K |
|
2117
Liberty Global Class A
LBTYA
$3.6B
| $2.34M | ﹤0.01% |
123,471
-114,233
| -48% | -$2.08M |
|
2118
Doximity
DOCS
$5B
| $2.33M | ﹤0.01% |
69,559
+11,961
| +21% | +$365K |
|
2119
CALL
Conagra Brands
CAG
$7.23B
| $2.33M | ﹤0.01% |
+60,200
| New | +$2.18M |
|
2120
Workiva
WK
$3.54B
| $2.32M | ﹤0.01% |
27,677
+4,227
| +18% | +$328K |
|
2121
Nkarta
NKTX
$172M
| $2.32M | ﹤0.01% |
387,271
-66,400
| -15% | -$670K |
|
2122
Veeco
VECO
$3.23B
| $2.31M | ﹤0.01% |
124,433
+16,174
| +15% | +$304K |
|
|
BLU
2123
DELISTED
BELLUS Health Inc.
BLU
| $2.31M | ﹤0.01% |
281,192
+41,788
| +17% | +$390K |
|
2124
Kura Oncology
KURA
$850M
| $2.31M | ﹤0.01% |
186,049
-44,493
| -19% | -$647K |
|
2125
Monro
MNRO
$398M
| $2.31M | ﹤0.01% |
51,005
+24,491
| +92% | +$1.13M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.